Home > Healthcare > Medical Devices > Therapeutic Devices > Lipid Nanoparticle Raw Materials Market

Lipid Nanoparticle Raw Materials Market Share

Report ID: GMI9266
Published Date: Apr 2024
Report Format: PDF

Download Free Sample

Lipid Nanoparticle Raw Materials Market Share

The lipid nanoparticle raw materials sector is competitive in nature, with a mix of major global and smaller to medium-sized companies competing for market share. A pivotal aspect of market strategy involves the continual introduction of innovative products leveraging diverse technologies. Notably, prominent industry players command significant influence in this dynamic landscape, often driving forward advancements through substantial investments in research and development. Additionally, strategic alliances, acquisitions, and mergers are instrumental in fortifying market positions and expanding global footprint amidst evolving regulatory landscapes.

Lipid Nanoparticle Raw Materials Market Companies

Some of the eminent market participants operating in the lipid nanoparticle raw materials industry include:

Biopharma PEG Scientific Inc.
BroadPharm
CordenPharma
Creative Biolabs
Croda International Plc
Echelon Biosciences
Merck KGaA
NOF Corporation
Polysciences, Inc.
Tebubio

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Lipid nanoparticle raw materials market size was USD 227.4 million in 2023 and is expected to register 5.7% CAGR from 2024-2032 owing to the rise in chronic diseases such as cancer, diabetes, and cardiovascular disorders worldwide.

Lipid nanoparticle raw materials industry from the kits segment is expected to reach USD 195.1 million by 2032 due to a rising demand for specialized lipid components such as ionizable lipids, PEGylated lipids, sterol lipids, and neutral phospholipids, essential for formulating lipid nanoparticles.

North America lipid nanoparticle raw materials industry reached USD 92.5 million in 2023 and is expected to register a commendable CAGR from 2024-2032 due to the rising incidence of chronic ailments like cancer and diabetes in the region.

Biopharma PEG Scientific Inc., BroadPharm, CordenPharma, Creative Biolabs, Croda International Plc, Echelon Biosciences, Merck KGaA, NOF Corporation, Polysciences, Inc., and Tebubio, are some of the major lipid nanoparticle raw materials companies worldwide.